ORAL ULCERATION Definition what is an ulcer Full

  • Slides: 21
Download presentation
ORAL ULCERATION

ORAL ULCERATION

Definition – what is an ulcer? Full thickness breach of the mucosal epithelium Exposes

Definition – what is an ulcer? Full thickness breach of the mucosal epithelium Exposes nerve endings underlying the lamina propria Typical symptoms – pain, soreness, discomfort when eating spicy, acidic foods Can be superficial or extend into tissues underlying the surface epithelium – to submucosa, muscle or periosteum

Classification Recurrent Apthous Stomatitis (RAS) Recurrent Oral Ulceration (ROS) – occurring secondary to known

Classification Recurrent Apthous Stomatitis (RAS) Recurrent Oral Ulceration (ROS) – occurring secondary to known or unknown systemic disease/infection Single episodes of ulceration – trauma, burns, iatrogenic, Squamous Cell Carcinoma See Table 1 for basic classification overview

Recurrent Apthous Stomatitis (RAS) Defines recurring episodes of ulceration in healthy individuals 20% prevalence

Recurrent Apthous Stomatitis (RAS) Defines recurring episodes of ulceration in healthy individuals 20% prevalence Occurring more commonly up to 30 yrs but can persist >30 yrs 3 sub-types: Minor, Major or Herpetiform – depending on keratanised/nonkeratanised surface and healing characteristics Features vary with sub-type

Recurrent Oral Ulceration (ROU) Patients with systemic disease may present with ROU The aetiology

Recurrent Oral Ulceration (ROU) Patients with systemic disease may present with ROU The aetiology and pathogenesis is directly linked to the underlying disorder Examples: o Crohn’s Disease o Behcet’s Syndrome o Orofacial Granulomatosis o Leukaemia

Table 1

Table 1

Pathogenesis of RAS Genetic predisposition – positive family history in approx. 1/3 patients Immunological

Pathogenesis of RAS Genetic predisposition – positive family history in approx. 1/3 patients Immunological Factors – T Helper cells & Natural Killer cells predominate in early lesions followed by cytotoxic cells & antibody dependant cellular cytotoxicity

Aetiology - RAS Genetic predisposition Immune Deficiency Hormonal link – fall in progesterone levels

Aetiology - RAS Genetic predisposition Immune Deficiency Hormonal link – fall in progesterone levels during menstrual cycle Mucosal Integrity Nutritional/Haematinic Deficiencies – e. g. iron, folate, vitamin B 12 Stress

Features of RAS Minor • Approx 80% of RAS cases • 10 -40 yrs

Features of RAS Minor • Approx 80% of RAS cases • 10 -40 yrs • Ovoid/round ulcers • <10 mm in diameter • Yellow with red halo • Non-keratinised mucosa e. g. lips, cheek, floor of mouth • Groups of 1 -6 ulcers • Heal in <14 days • No scarring

Major • 10% of RAS cases • >10 mm • Crops of 2 -5

Major • 10% of RAS cases • >10 mm • Crops of 2 -5 ulcers • Keratinised and non-keratinised mucosa • Heal with scarring • Longer duration – can last several weeks (10 -40 days) • More painful than minor • Frequent recurrence

Herpetiform • Common in older groups & females • Recurrent crops of small ulcers

Herpetiform • Common in older groups & females • Recurrent crops of small ulcers – multiple pinhead ulcers (which may look “herpetic”) – 0. 5 -3 mm • Can increase in size to leave large ragged ulcers • Any oral site • Heal without scarring up to 14 days • Extremely painful • Occur continuously

Aetiology - ROU Pathogenesis directly linked to underlying medical disorder Secondary to systemic or

Aetiology - ROU Pathogenesis directly linked to underlying medical disorder Secondary to systemic or infectious disease Haematological – Neutropenia, Leukaemia Rheumatological – Reactive Arthritis Gastrointestinal – Chrons disease, ulcerative colitis, OFG Dermatological – Lichen Planus, Erythema multiforme Viral – HIV, ANUG, Herpetic gingivostomatitis Bacterial – Tuberculosis Behcet’s Syndrome

Behcet’s Syndrome • Auto-inflammatory condition • Apthous like oro-genital ulceration and ocular disease –

Behcet’s Syndrome • Auto-inflammatory condition • Apthous like oro-genital ulceration and ocular disease – uveitis • More common in males in 3 rd decade • Racial distribution – countries bordering the Mediterranean due to genetic predisposition – HLA tissue types associated HLA-B 12, HLA-DR 2 and HLA-B 51 • Diagnosis based on following criteria – a patient should have one major and two minor of the following: Major Recurrent oral ulceration Recurrent genital ulceration Ocular disease Cutaneous disease Minor Sero-negative arthritis Gastrointestinal disease Vascular Complications Central nervous system involvement

Behcet’s contd… • Oral ulceration similar to RAS • More frequent episodes • More

Behcet’s contd… • Oral ulceration similar to RAS • More frequent episodes • More ulcers per crop • Soft palate and oropharynx more commonly involved • More pronounce scarring • Greater resistance to treatment

Reactive Arthritis (Reiter’s Syndrome) Autoimmine condition Inflammation of large joints Inflammation of the eyes

Reactive Arthritis (Reiter’s Syndrome) Autoimmine condition Inflammation of large joints Inflammation of the eyes – conjunctivitis or uveitis Urethritis Mucocutaneous lesions Patients may present with apthous type ulceration

Single episodes of ulceration Trauma – burns - chemical, thermal Iatrogenic Non-accidental injury Cessation

Single episodes of ulceration Trauma – burns - chemical, thermal Iatrogenic Non-accidental injury Cessation of smoking may aggravate ulceration

Diagnosis Based on history and clinical features To exclude underlying systemic conditions diagnostic testing

Diagnosis Based on history and clinical features To exclude underlying systemic conditions diagnostic testing as follows is required: Full Blood count, Haematinics – ferritin, folate, vitamin B 12 Serological test for coeliac disease - tissue transglutaminase antibody or antiendomysial antibody Clinical Features: site, size, shape, number of ulcers in crop, frequency & duration of episodes, age of onset, any systemic features? Tissue biopsy if SCC suspected

Management & Treatment First Line Therapies Good OH Dispersible Doxycycline (100 mg) & CHX

Management & Treatment First Line Therapies Good OH Dispersible Doxycycline (100 mg) & CHX mouthwashes Topical Analgesics – 0. 15% Benzydamine Hydrochloride (Difflam) or 1% Lidocaine ointment Mucosal protectants – carboxymethylcellulose (orobase) Topical Corticosteroids (on prescription) – 2. 5 mg Hydrocortisone muco-adhesive buccal tablet, 0. 5 mg soluble betamethasone phosphate tablets (mouthwash) or Beclometasone Dipropionate Spray Fluticasone propionate spray, mouthwash or ointment (off prescription)

Second Line Therapies Systemic corticosteroid/immunosuppressive treatment for severe cases Azathioprine Clofazimine Colchicine *Only under

Second Line Therapies Systemic corticosteroid/immunosuppressive treatment for severe cases Azathioprine Clofazimine Colchicine *Only under consultant-led treatment*

Referral of Suspicious Lesions When to Refer? ? Single ulcers persisting for longer than

Referral of Suspicious Lesions When to Refer? ? Single ulcers persisting for longer than 3 weeks Ulcers with an indurated border Ulceration unresponsive to topical therapy ROU of uncertain aetiology RAS impacting on an individuals quality of life Suspected SCC – URGENT referral

References ORAL ULCERATION: AN OVERVIEW OF DIAGNOSIS AND MANAGEMENT PRIYA THAKRAR, SHAHID I CHAUDHRY

References ORAL ULCERATION: AN OVERVIEW OF DIAGNOSIS AND MANAGEMENT PRIYA THAKRAR, SHAHID I CHAUDHRY Prim Dent J. 2016; 5(1): 30 -33 Oral Medicine: 1. Ulcers: Aphthous and other Common Ulcers David H Felix, Jane Luker, Crispian Scully Dental Update 2012; 513 -519